Introduction
Deoxyribonucleic acid (DNA) is an important genetic substance in organisms. The areas of DNA involved in vital processes such as gene expression, gene transcription, mutagenesis, carcinogenesis and cell death, etc., are of particular interest as targets for a wide range of anticancer and antibiotic drugs. In recent years, the interactions of drugs with DNA and the investigation of new effective DNA probes have attracted considerable interest and have become an important research field of life science. [1] [2] [3] [4] The fluoroquinolones are one of the most useful classes of synthetic antibacterial agents due to their broad spectrum of activity against both Gram-positive and Gram-negative bacteria. A number of fluoroquinolones have recently been introduced for clinical use, and some members of this class of drugs will soon be marketed. It was reported earlier that the primary target for fluoroquinolones is DNA. 5 Sinafloxacin is a novel fourth-generation quinolone antimicrobial drug, which has in vitro and in vivo activities against a wide range of Gram-positive and Gram-negative bacteria.
Its chemical structure is depicted in Fig. 1 . In a previous study, it was observed that sinafloxacin had more potent antibacterial activity but lower cytotoxicity than ciprofloxacin, levofloxacin and gatifloxacin. 6, 7 Consequently, binding studies of sinafloxacin with DNA are useful for the understanding of the interaction mechanism and the differences in the biological activity of its analogues, and for providing some important information needed in the application and design of new and more efficient drugs targeted to DNA.
In terms of the mechanism, it is generally accepted that small molecules are bound to DNA by three binding modes: electrostatic binding, intercalative binding and groove binding. 8 Electrostatic binding is the interaction between cationic species and the negatively charged DNA phosphate backbone that occurs along the external DNA double helix and does not possess selectivity. Intercalation binding was first proposed by Lerman in 1961, 9 and typically intercalative small molecules possesses a planar aromatic system that can insert between two adjacent base pairs in a helix. In groove binding, the interactions with the two grooves of the DNA double helix generally involve direct hydrogen bonding or van der Waals interactions with the nucleic acid bases in the deep major groove or the shallow minor groove of the DNA helix.
The binding of sinafloxacin to DNA has been studied by fluorescence spectroscopy and UV-vis absorption spectroscopy. The variations in the spectroscopic characteristics of sinafloxacin upon addition of DNA were observed. Salt concentration effect, KI quenching, fluorescence polarization, DNA denaturation experiments, melting temperature (Tm) curves and viscosity measurements were studied to investigate the binding mechanism. It was proved that the fluorescence quenching of sinafloxacin is a result of the formation of sinafloxacin-DNA complex. Quenching constants were determined using the Stern-Volmer equation. From the experiment evidence, the major binding mode of sinafloxacin with DNA was evaluated to be the groove binding. In the absence of high resolution structural data, the mode of binding is, of necessity, usually inferred indirectly from the results of various studies. UV-vis spectrophotometry and fluorescence quenching technique are powerful tools since they allow non-intrusive measurements of substances. In this work, the binding of sinafloxacin with DNA was first reported by spectroscopic techniques. Studies of the effects of ionic strength and the measurements of viscosity and melting temperatures were also carried out to prove the binding mechanism.
Experimental

Apparatus
The fluorescence measurements were performed on a Cary Eclipse spectrofluorometer (Varian, USA), using a 1 × 1 cm cross-section quartz cell of path length. UV spectra were recorded with a Cary 50 UV-vis spectrophotometer (Varian, USA). The pH values of the solution were measured with a pHS-3B acidity meter (Leici, Shanghai).
Reagents
Calf thymus DNA (purity >99.0%) was purchased from Sigma Chem. Co., and used without further purification. The stock solution of DNA was prepared by directly dissolving an appropriate amount of solid DNA in 0.01 M NaCl solution overnight and this solutions were stored at 4 C in the dark for about a week only. The purity of the final DNA preparation was checked by monitoring the ratio of the absorbance at 260 nm to that at 280 nm. The solution gave a ratio of A260/A280 >1.8, indicating that DNA was sufficiently free from protein. 10 Its concentration was determined to be 2.76 × 10 -3 M spectrophotometrically using a molar extinction coefficient of ε260 (25 C) = 6600 L mol -1 cm -1 . 11 Sinafloxacin was provided by Jiangsu Haosheng Medicine Co. Ltd. (Jiangsu, China). The 2% sinafloxacin (w/v) was prepared in sterile water, and was diluted by doubly distilled water before use. A 0.05 M tris-(hydroxymethyl)aminomethane-HCl solution (pH 7.40) is used to control the acidity of the reaction system. NaCl was used to adjust the ionic strength of the aqueous solutions. The DNA used in this work was double stranded DNA (dsDNA) unless otherwise specified. All reagents were of analytical reagent grade unless otherwise stated. Doubly distilled water is used throughout the work.
Spectral measurements
The fluorescence titrations with DNA were conducted by fixing the concentration of sinafloxacin while varying the DNA concentration. Samples were excited at 286 nm and emission spectra were recorded in the range from 290 to 550 nm. Both slits for the excitation and emission were 5 nm in width and the scan rate was 600 nm min -1 . The salt effect experiments were conducted by adding various amounts of NaCl to sinafloxacin and sinafloxacin-DNA mixture, respectively. Iodide quenching experiments were carried out by adding various concentrations of potassium iodide stock solution to sinafloxacin and sinafloxacin-DNA mixture, respectively. While DNA with increasing concentration was added into the solution containing sinafloxacin, the UV-vis spectra were recorded.
DNA melting studies
The general method of determining the melting temperatures (Tm) is UV-vis spectroscopy. The experiments were carried out by monitoring the absorption of the sample at various temperatures in the absence and presence of sinafloxacin. The absorption were then plotted as a function of temperature ranging from 25 to 100 C. The data were recorded every other 2 -5 C. The melting temperature (Tm) of DNA was determined as the transition midpoint.
Viscosity measurements
Viscosity measurements were performed by using a viscometer, which was immersed in a thermostat water-bath maintained at 25 ± 0.1 C. Samples were prepared by adding an appropriate amount of sinafloxacin separately to DNA so as to give the [sinafloxacin]/[DNA] ratios in the range of 0.02 -0.5. After a thermal equilibrium time of 15 min, the flow times of samples were repeatedly measured with an accuracy of ±0.2 s by using a digital stopwatch, and each point measured was the average of at least five readings. The relative viscosity values were calculated from the flow time of DNA-containing solution (t) and the flow time of buffer alone (t0), using the following Eq. (1):
The data were presented as (η/η0) 1/3 versus binding ratio, where η is the viscosity of DNA in the presence of sinafloxacin and η0 is the viscosity of DNA alone.
Results and Discussion
UV-vis spectral studies
The absorption spectra of sinafloxacin and of the mixture of DNA and sinafloxacin are given in Fig. 2 . The UV-vis spectra of the sinafloxacin are characterized by two transitions: a lower energy absorption in the 310 -360 nm region (band I), and a higher energy band in the 260 -300 nm region (band II). When DNA was added, the maximum absorption wavelength of sinafloxacin was occurred at the same position. There was a new absorption peak at 260 nm for DNA. The binding of sinafloxacin to DNA also has been characterized classically through absorption titrations. The spectral changes in the presence of DNA are clearly observed. Generally, bathochromic and hypochromic effects are observed in the absorption spectra of small molecules if they intercalate with DNA. 12, 13 From Fig. 3 , it can be seen that the maximum absorption wavelength of sinafloxacin did not exhibit red-shift and the absorption has little change in intensity and shape after adding DNA into the system. An isobestic point was also observed at 285 nm. This was evidence of drug-DNA complex formation. These results suggest that there existed interactions between sinafloxacin with DNA and that the binding mode is not the classical intercalation binding, so that the groove binding mode appears to be more acceptable.
Fluorescence quenching studies
The fluorescence intensity of a compound can be decreased by a variety of molecular interactions, such as excited-state reactions, molecular rearrangments, energy transfer, and ground-state complex formation. 14, 15 Such a decrease in intensity is called fluorescence quenching. Stern-Volmer Ksv is used to evaluate the fluorescence quenching efficiency. According to the classical Stern-Volmer equation: 16
where F0 and F are the fluorescence intensities before and after the addition of the quencher, respectively.
[Q] is the concentration of the quencher, and Ksv is the quenching constant. Based on the quenching of fluorescence, an experimental strategy for determining the quenching constant of the ligand molecule interacting with DNA has become a standard method in nucleic acid chemistry. It is very useful to estimate the biological activities of some drug molecules because their biological activities correlate well with DNA binding affinity. Figure 4 shows the characteristic changes in fluorescence emission spectra during the titration of sinafloxacin with DNA. The concentration of sinafloxacin (2.5 × 10 -6 M) was fixed and the concentration of DNA was varied in assay solutions. The results show that the fluorescence intensity of sinafloxacin at 469 nm is decreased dramatically, but there is no shift in the emission wavelength. This quenching spectrum is evidence of direct interaction between sinafloxacin and DNA.
It is well known that there are two quenching processes: static and dynamic quenching. 17, 18 They can be distinguished by their differing dependence on temperature. Higher temperatures result in faster diffusion and hence larger amounts of collisional quenching. So Ksv increases with increasing temperature. And for static quenching, higher temperatures will typically result in the dissociation of weakly bound complexes, so Ksv decreases with increasing solvent temperature. The nature of the quenching process was inferred by comparison of the behavior of the Stern-Volmer plots at 25 and 37 C. The Stern-Volmer graphs are shown in Fig. 5 . The results show that the SternVolmer quenching constant Ksv is inversely correlated with temperature, K25 C = 4320 L mol -1 and K37 C = 4100 L mol -1 , which support the conclusion that the probable quenching mechanism of sinafloxacin-DNA binding reaction is initiated by forming a non-fluorescent complex formation rather than by dynamic collision.
19,20
Effect of ionic strength on the fluorescence properties
The study of the ionic strength effect is also an efficient method to distinguish the binding mode between molecules and DNA. Increasing the cation concentration will increase the combination probability between cation and DNA phosphate backbone. Due to a competition for phosphate anion, the addition of cations will weaken the surface-binding mode of interaction between DNA and drug molecules. 21, 22 It is apparent that intercalative binding and groove binding are related to the groove in the DNA double helix, but the electrostatic binding can take place out of the groove. In our experiments, the fluorescence of sinafloxacin-DNA system in a gradual increasing of NaCl concentration was studied. The results showed that the fluorescence intensity ratio had no significant change when the concentration of NaCl was within 0 -0.2 M range (Fig. 6 ). Such data indicated that the interaction between sinafloxacin and DNA was not surface-binding mode. 
Influence of denaturation of DNA
In the assay, the binding of sinafloxacin and single stranded DNA (ssDNA) was investigated. The ssDNA was obtained by heating the double stranded DNA (dsDNA) in a boiling water bath for 30 min and then quickly cooling in an ice-water bath for 10 min. 12 The natural DNA split into two string-like soft polynucleotide chains from the original rigid double-helix structure, which caused the difference in the fluorescence quenching. The test on sinafloxacin binding with ssDNA should be accomplished within 3 h for fear that the denatured DNA regenerates. The experiments showed that ssDNA could quench the fluorescence of sinafloxacin linearly, and the quenching of the fluorescence from sinafloxacin by dsDNA was a little smaller than that by ssDNA under the same conditions (Fig. 7) . If sinafloxacin intercalates between the adjacent base pairs of DNA, the denatured DNA cannot quench the fluorescence intensity of sinafloxacin at all. Electrostatic binding is the interaction between cationic species and the negatively charged DNA phosphate backbone that occurs along the external DNA double helix, so it should exhibit a similar fluorescence quenching effect to those of both dsDNA and ssDNA. When the groove binding is the major binding mode for the studied systems, even though the major and minor grooves are destroyed, ssDNA has a line-and-knot conformation, and the surfaces of the knots have concavity sites that can form hydrogen bonds with small molecules. As a result, there is still a fluorescence quenching effect. 21 So it is reasonable that the sinafloxacin binding to DNA is groove binding.
Fluorescence polarization studies
Fluorescence polarization experiments provide an effective parameter for investigating dynamic characteristics of sinafloxacin in different microenvironments. Small molecules weakly polarize due to the rapid tumbling motion in aqueous media. However, when intercalating to the helix of DNA, the small molecule has rotational motion which should be restricted and therefore the fluorescence polarization should be increased. On the contrary, binding to the phosphate backbone or to the DNA grooves does not result in obviously enhanced fluorescence polarization. 8, 23 The value of fluorescence polarization can be calculated from the equation below:
Where P is the fluorescence polarization, IVV and IVH are the fluorescence intensities measured through vertically and horizontally oriented polarizers in the excitation beam and emission beam, respectively. G represents the corrected instrumental factor and is equal to IHV/IHH. IHV is the vertical polarization intensity parallel with excitation; IHH is the horizontal polarization intensity parallel with excitation. Fluorescence polarization measurements were performed on steady state sinafloxacin-DNA solutions. The results are shown in Fig. 8 . Only a slight increase was obtained with the addition of DNA. Such a result illustrates that the binding of sinafloxacin with DNA is not the classical intercalation binding, and this becomes another proof of the binding mode between sinafloxacin and DNA.
Iodide quenching studies
Since groove binding exposes the bound molecules to the solvent surrounding the helix much more than does the intercalation, the iodide quenching experiment was chosen to further establish the DNA binding affinity of sinafloxacin. Iodide ions are dynamic, or collision, fluorescence quencher for the small fluorescent molecules. They can effectively quench the fluorescence of a small molecule. The binding mode of the small molecule with DNA can be deduced from the variation of the fluorescence in the absence and the presence of DNA. If sinafloxacin is intercalated into the helix stack, it should be protected from the anionic quencher, owing to the base pairs above and below the intercalator and the electrostatic repelling between DNA phosphate backbone and the iodide anions. 24, 25 The magnitude of Ksv, of the free sinafloxacin should be much higher than that of the bound sinafloxacin. However, groove binding should provide much less protection for the chromophore, and iodide anions still can quench its fluorescence. The quenching behaviors of KI in the sinafloxacin-DNA system were shown in Fig. 9 . In aqueous solutions, iodide quenched the fluorescence of sinafloxacin efficiently. The Ksv values between sinafloxacin and iodide anions with the presence of DNA decreased slightly, which indicated that sinafloxacin could be partly protected. Therefore, the binding mode of sinafloxacin with DNA should be groove binding.
Melting studies
Interactions of small molecules with the double helix are known to influence the melting temperature (Tm), the temperature at which the double helix denatures into single stranded DNA. Intercalation binding can stabilize the double helix structure and Tm increases by about 5 -8 C, but the non-intercalation binding causes no obvious increase in Tm. 16, 24 The value of Tm for DNA-sinafloxacin was determined, by monitoring the absorbance of the systems at 260 nm as a function of temperature ranged from 25 to 100 C. For each monitored transition, the Tm of the assay solution was determined as the transition midpoint of the melting curve. The melting curves are shown in Fig. 10 .
The value of Tm for DNA in the absence of sinafloxacin is 72 ± 1 C under the experimental conditions. The observed Tm of DNA in the presence of sinafloxacin is 74 ± 1 C. The observed change in Tm once more proved that the binding mode was non-intercalated. The slight increase in Tm is presumably due to the groove binding of sinafloxacin with DNA, which changes the conformation of DNA to some degree.
Viscometric studies
The measurement of viscosity of DNA is regarded as the least ambiguous and the most effective tool to decide the binding modes of small molecules and DNA. 9, 26 As a means to further clarify the mode of binding of sinafloxacin to DNA, the viscosity measurements were carried out on DNA by varying the concentration of sinafloxacin at 25.0 C. It has already been proved that a classical intercalation binding demands that the space of adjacent base pairs be large enough to accommodate the bound ligand, which would cause elongation of DNA polymer and result in an increase in viscosity. In contrast, some drug molecules those bind in the grooves of DNA, under the same conditions, causing less increasing or no changes in DNA solution viscosity. 25, [27] [28] [29] As shown in Fig. 11 , the addition of sinafloxacin caused no appreciable viscosity change in our experiments. Such behavior proved from another way that the interaction between sinafloxacin and DNA belongs to the groove-binding mode.
The composition of the binary complex
If the static binding reaction between the DNA and drug happens, and if there are the similar and independent binding sites n in the DNA, namely, if the binding capability of DNA at each binding site is equal, then the composition of the binary complex can be deduced from the following formula: [29] [30] [31] [32] 
where M is the quencher, and L the pharmaceutical molecule with a fluorophore, MLn the binary complex whose resultant constant is Ka, F0 the fluorescence of the total amount of the pharmaceutical molecules (bound and unbound), and F the fluorescence of unbound pharmaceutical molecules. A plot of log[(F0 -F)/F] versus log[M] will give a straight line with a slope of n and a y-axis intercept log Ka. The fluorescence titration data are well fitted to Eq. (5) and can be used to 
Conclusions
In this paper, the characteristics of sinafloxacin binding with DNA were studied by spectroscopic methods including fluorescence spectroscopy and UV-vis absorption spectroscopy. Sinafloxacin binding with DNA forms a new non-fluorescence complex, which causes the fluorescence quenching. The binding constant and the number of binding sites were calculated. The groove binding, through which sinafloxacin interacted reversibly with DNA, was found to be more likely by taking account of ionic strength effects, tests for the ability binding with dsDNA and ssDNA, fluorescence polarization studies and iodide quenching studies. This conclusion is further reinforced by melting experiments and viscosity measurements. Groove binding is related to the two kinds of grooves in DNA: major grooves and minor grooves. The small molecules such as drugs interact with DNA more readily in the minor groove due to their small sizes. By the suitable torsion the small molecules can fit into the target groove curve. The results provide useful information about drug-DNA interactions, which are valuable for the rational design of drugs that are more efficient as well as for understanding the binding mechanism of these drugs at the molecular level.
